CLOV

CLOV

USD

Clover Health Investments Corp. Class A Common Stock

$3.340+0.010 (0.300%)

即時價格

Healthcare
Healthcare Plans
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$3.330

最高

$3.400

最低

$3.254

交易量

0.44M

公司基本面

市值

1.7B

行業

Healthcare Plans

國家

United States

交易統計

平均交易量

5.66M

交易所

NMS

貨幣

USD

52週範圍

最低 $0.693當前 $3.340最高 $4.87

AI分析報告

最後更新: 2025年5月3日
由AI生成數據來源: Yahoo Finance, Bloomberg, SEC

CLOV: Clover Health Investments Corp. Class A Common Stock - Analyzing Recent Moves & What Might Come Next

Stock Symbol: CLOV Generate Date: 2025-05-03 20:26:19

Alright, let's break down what's been going on with Clover Health stock (CLOV) based on the latest information. We'll look at the recent news, check out what the price has been doing, and see what the AI crystal ball is hinting at.

Recent News Buzz - What's the Vibe?

Looking at the news headlines from the past couple of weeks, things seem to lean pretty positive for Clover Health.

First off, there's news about their subsidiary, Counterpart Health, and how using their tech with primary care doctors is linked to better results for patients dealing with congestive heart failure. That's a good sign, suggesting their technology platform, the Clover Assistant, is actually making a difference in patient care.

Then, there's a broader piece talking about how AI in healthcare could unlock billions in market value. This is relevant because Clover Health specifically uses AI through its Clover Assistant platform to help doctors. So, if the AI trend in healthcare is big, Clover is positioned right in the middle of it.

We also saw news about changes to the company's Board of Directors and plans to participate in upcoming investor conferences. Board changes are often just standard corporate stuff, not necessarily good or bad on their own. But going to investor conferences? That usually means the company is actively talking to potential investors, which is generally seen as a positive step.

So, putting it together, the recent news flow feels constructive. It highlights the potential benefits of their core technology and shows the company is engaging with the financial community.

Price Check - What's the Stock Been Doing?

Now, let's look at the stock price itself over the last couple of months. If you glance at the historical data, you'll see that after trading in the $4 range back in February, the price started a noticeable slide through March. It hit lows around the mid-$3 mark.

In April, the price seemed to find a bit of a floor, mostly bouncing around between $3.40 and $3.70, though there was one sharp dip below $3 briefly. More recently, in the last few days of April and early May, the stock has been trading pretty tightly, hovering right around the $3.30 to $3.40 level. The previous day's close was $3.32.

What about the AI's prediction for the very near future? The AI model suggests the price will stay flat today (0.00% change), but then tick up slightly over the next two days, predicting a 1.06% rise tomorrow and a 1.78% rise the day after. This suggests the AI sees a small upward move coming from the current price point.

Outlook & Strategy Ideas - Putting It All Together

So, what does this mix of news, price action, and AI prediction suggest?

The positive news about their tech and the broader AI trend in healthcare provides a potentially favorable backdrop. The price has been weak overall but seems to have settled into a recent range, and the AI is forecasting a modest bounce from here.

Based on this, the current situation might lean towards a 'hold' or perhaps a cautious 'accumulate' stance for those interested in the stock. The price is near the lower end of its recent trading range and close to a potential support level mentioned in the recommendation data ($3.35).

If you were considering getting involved, a potential entry area could be around the current price level, say between $3.30 and $3.40. This aligns with where the stock has been trading recently and where the AI predicts a slight upward move starting.

Thinking about managing risk, the recommendation data suggests a potential stop-loss level around $3.00. This is below the recent trading range and offers some room before cutting losses if the price were to fall further. For taking profits, the recommendation points to $3.40, which is right at the top of the recent tight trading range and aligns somewhat with the AI's short-term upward forecast. It could be a potential near-term target to watch.

Company Context

Just remember, Clover Health is primarily focused on Medicare Advantage plans and uses its technology platform, Clover Assistant, as a key part of its strategy. So, news related to healthcare tech, AI in medicine, and government programs like Medicare are particularly important to watch for this company.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

相關新聞

GlobeNewswire

Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure

WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. ("Counterpart"), a wholly owned subsidiary of Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company") and

查看更多
Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure
PR Newswire

New Advances in Healthcare AI Could Unlock Billions in Market Opportunity

Artificial intelligence is making deeper inroads into western healthcare, targeting the slow grind of authorizations and paperwork that bog down...

查看更多
New Advances in Healthcare AI Could Unlock Billions in Market Opportunity
GlobeNewswire

Clover Health Announces Changes to Board of Directors

WILMINGTON, Del., April 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced that after four years of distinguished service, Lee A.

查看更多
Clover Health Announces Changes to Board of Directors
GlobeNewswire

Clover Health to Participate in Upcoming Investor Conferences

WILMINGTON, Del., April 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced its participation in the following investor conferences:

查看更多
Clover Health to Participate in Upcoming Investor Conferences

AI預測Beta

AI推薦

看漲

更新於: 2025年5月3日 下午01:07

看跌中立看漲

61.9% 信心度

風險與交易

風險級別3/5
中等風險
適合
價值積極
交易指南

入場點

$3.34

獲利了結

$3.40

止損

$3.00

關鍵因素

DMI 顯示熊市趨勢 (ADX:13.6, +DI:6.1, -DI:9.1),建議謹慎
當前價格非常接近支撐位 ($3.35),表明強勁的買入機會
交易量是平均值 (66,122) 的 5.4 倍,表明極強的買入壓力
MACD -0.0017 在信號線 0.0016 下方,表示看跌交叉

保持更新

設定價格提醒,獲取AI分析更新和即時市場新聞。